Osteoporosis has been defined as the silent disease of the 21st century, becoming a public
health risk due to its severity, chronicity and progression and affecting mainly …

This report describes the epidemiology, burden, and treatment of osteoporosis in the 27
countries of the European Union (EU27). Introduction Osteoporosis is characterized by …

Corticosteroid-induced osteoporosis is the most common form of secondary osteoporosis
and the first cause in young people. Bone loss and increased rate of fractures occur early …

This study in 8 countries across Europe found that about 75% of elderly women seen in
primary care who were at high risk of osteoporosis-related fractures were not receiving …

Glucocorticoids are effective immunomodulatory drugs used for many inflammatory
disorders as well as in transplant recipients. However, both iatrogenic and endogenous …

This paper provides a framework for the development of national guidelines for the
management of glucocorticoid-induced osteoporosis in men and women aged 18 years and …

Glucocorticoids are widely used for their unsurpassed anti-inflammatory and
immunomodulatory effects. However, the therapeutic use of glucocorticoids is almost always …

Osteoporosis is a silent disease with increasing prevalence due to the global ageing
population. Decreased bone strength and bone quality is the hallmark of osteoporosis which …

Among the adverse events of glucocorticoid treatment are bone loss and fractures. Despite
available, effective preventive measures, many patients receiving or initiating glucocorticoid …

Despite the continued development of specialized immunosuppressive therapies in the form
of monoclonal antibodies, glucocorticoids remain a mainstay in the treatment of …